Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133


Downregulation of GAS5 promotes bladder cancer cell proliferation, partly by regulating CDK6.

Liu Z, Wang W, Jiang J, Bao E, Xu D, Zeng Y, Tao L, Qiu J.

PLoS One. 2013 Sep 17;8(9):e73991. doi: 10.1371/journal.pone.0073991. eCollection 2013.


Downregulation of gas5 increases pancreatic cancer cell proliferation by regulating CDK6.

Lu X, Fang Y, Wang Z, Xie J, Zhan Q, Deng X, Chen H, Jin J, Peng C, Li H, Shen B.

Cell Tissue Res. 2013 Dec;354(3):891-6. doi: 10.1007/s00441-013-1711-x. Epub 2013 Sep 12.


Long non‑coding RNA‑GAS5 acts as a tumor suppressor in bladder transitional cell carcinoma via regulation of chemokine (C‑C motif) ligand 1 expression.

Cao Q, Wang N, Qi J, Gu Z, Shen H.

Mol Med Rep. 2016 Jan;13(1):27-34. doi: 10.3892/mmr.2015.4503. Epub 2015 Nov 5.


Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer.

Sun M, Jin FY, Xia R, Kong R, Li JH, Xu TP, Liu YW, Zhang EB, Liu XH, De W.

BMC Cancer. 2014 May 6;14:319. doi: 10.1186/1471-2407-14-319.


GAS5 Inhibits Gastric Cancer Cell Proliferation Partly by Modulating CDK6.

Guo X, Deng K, Wang H, Xia J, Shan T, Liang Z, Yao L, Jin S.

Oncol Res Treat. 2015;38(7-8):362-6. doi: 10.1159/000433499. Epub 2015 Jul 1.


Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer.

Cao S, Liu W, Li F, Zhao W, Qin C.

Int J Clin Exp Pathol. 2014 Sep 15;7(10):6776-83. eCollection 2014.


MicroRNA-320c inhibits tumorous behaviors of bladder cancer by targeting Cyclin-dependent kinase 6.

Wang X, Wu J, Lin Y, Zhu Y, Xu X, Xu X, Liang Z, Li S, Hu Z, Zheng X, Xie L.

J Exp Clin Cancer Res. 2014 Sep 2;33:69. doi: 10.1186/s13046-014-0069-6.


Decreased expression of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion, and indicates a poor prognosis in ovarian cancer.

Li J, Huang H, Li Y, Li L, Hou W, You Z.

Oncol Rep. 2016 Dec;36(6):3241-3250. doi: 10.3892/or.2016.5200. Epub 2016 Oct 24.


GAS5 long non-coding RNA in malignant pleural mesothelioma.

Renganathan A, Kresoja-Rakic J, Echeverry N, Ziltener G, Vrugt B, Opitz I, Stahel RA, Felley-Bosco E.

Mol Cancer. 2014 May 23;13:119. doi: 10.1186/1476-4598-13-119.


lncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer.

Liu Y, Zhao J, Zhang W, Gan J, Hu C, Huang G, Zhang Y.

Sci Rep. 2015 May 11;5:10159. doi: 10.1038/srep10159.


Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer.

Chen M, Zhuang C, Liu Y, Li J, Dai F, Xia M, Zhan Y, Lin J, Chen Z, He A, Xu W, Zhao G, Guo Y, Cai Z, Huang W.

Cancer Lett. 2016 Jun 28;376(1):155-64. doi: 10.1016/j.canlet.2016.03.037. Epub 2016 Mar 24.


Knockdown of a novel lincRNA AATBC suppresses proliferation and induces apoptosis in bladder cancer.

Zhao F, Lin T, He W, Han J, Zhu D, Hu K, Li W, Zheng Z, Huang J, Xie W.

Oncotarget. 2015 Jan 20;6(2):1064-78.


Long noncoding RNA GAS5 inhibits malignant proliferation and chemotherapy resistance to doxorubicin in bladder transitional cell carcinoma.

Zhang H, Guo Y, Song Y, Shang C.

Cancer Chemother Pharmacol. 2017 Jan;79(1):49-55. doi: 10.1007/s00280-016-3194-4. Epub 2016 Nov 22.


Long non-coding RNA LOC572558 inhibits bladder cancer cell proliferation and tumor growth by regulating the AKT-MDM2-p53 signaling axis.

Zhu Y, Dai B, Zhang H, Shi G, Shen Y, Ye D.

Cancer Lett. 2016 Oct 1;380(2):369-74. doi: 10.1016/j.canlet.2016.04.030. Epub 2016 Apr 26.


Decreased expression of long non-coding RNA GAS5 indicates a poor prognosis and promotes cell proliferation and invasion in hepatocellular carcinoma by regulating vimentin.

Chang L, Li C, Lan T, Wu L, Yuan Y, Liu Q, Liu Z.

Mol Med Rep. 2016 Feb;13(2):1541-50. doi: 10.3892/mmr.2015.4716. Epub 2015 Dec 24.


Long non-coding RNA growth arrest specific transcript 5 acts as a tumour suppressor in colorectal cancer by inhibiting interleukin-10 and vascular endothelial growth factor expression.

Li Y, Li Y, Huang S, He K, Zhao M, Lin H, Li D, Qian J, Zhou C, Chen Y, Huang C.

Oncotarget. 2017 Feb 21;8(8):13690-13702. doi: 10.18632/oncotarget.14625.


Low expression of lncRNA-GAS5 is implicated in human primary varicose great saphenous veins.

Li L, Li X, The E, Wang LJ, Yuan TY, Wang SY, Feng J, Wang J, Liu Y, Wu YH, Ma XE, Ge J, Cui YY, Jiang XY.

PLoS One. 2015 Mar 25;10(3):e0120550. doi: 10.1371/journal.pone.0120550. eCollection 2015.


Reciprocal regulation of GAS5 lncRNA levels and mTOR inhibitor action in prostate cancer cells.

Yacqub-Usman K, Pickard MR, Williams GT.

Prostate. 2015 May;75(7):693-705. doi: 10.1002/pros.22952. Epub 2015 Feb 3.


MicroRNA-892b influences proliferation, migration and invasion of bladder cancer cells by mediating the p19ARF/cyclin D1/CDK6 and Sp-1/MMP-9 pathways.

Shin SS, Park SS, Hwang B, Moon B, Kim WT, Kim WJ, Moon SK.

Oncol Rep. 2016 Oct;36(4):2313-20. doi: 10.3892/or.2016.5052. Epub 2016 Aug 25.


A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer.

Shi X, Sun M, Liu H, Yao Y, Kong R, Chen F, Song Y.

Mol Carcinog. 2015 Jun;54 Suppl 1:E1-E12. doi: 10.1002/mc.22120. Epub 2013 Dec 19.


Supplemental Content

Support Center